Alzheimer disease: from molecular biology to therapy
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Boston [u.a.]
Birkhäuser
1997
|
| Schriftenreihe: | Advances in Alzheimer disease therapy
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XIV, 613 S. graph. Darst. |
| ISBN: | 3764338792 0817638792 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV013377434 | ||
| 003 | DE-604 | ||
| 007 | t | ||
| 008 | 001009s1997 d||| |||| 00||| eng d | ||
| 016 | 7 | |a 949348589 |2 DE-101 | |
| 020 | |a 3764338792 |9 3-7643-3879-2 | ||
| 020 | |a 0817638792 |9 0-8176-3879-2 | ||
| 035 | |a (OCoLC)469734132 | ||
| 035 | |a (DE-599)BVBBV013377434 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 |a DE-355 |a DE-634 | ||
| 082 | 1 | |a 618.976 831 |2 22 | |
| 084 | |a YG 4000 |0 (DE-625)153494:12905 |2 rvk | ||
| 245 | 1 | 0 | |a Alzheimer disease |b from molecular biology to therapy |c Robert E. Becker ... ed. |
| 264 | 1 | |a Boston [u.a.] |b Birkhäuser |c 1997 | |
| 300 | |a XIV, 613 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Advances in Alzheimer disease therapy | |
| 650 | 7 | |a Alzheimer, Maladie d' - Aspect moléculaire |2 ram | |
| 650 | 7 | |a Alzheimer, Maladie d' - Thérapeutique |2 ram | |
| 650 | 0 | 7 | |a Therapie |0 (DE-588)4059798-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Alzheimerkrankheit |0 (DE-588)4112510-1 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Alzheimerkrankheit |0 (DE-588)4112510-1 |D s |
| 689 | 0 | 1 | |a Therapie |0 (DE-588)4059798-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Becker, Robert E. |e Sonstige |4 oth | |
| 856 | 4 | 2 | |m DNB Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009124399&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-009124399 | |
Datensatz im Suchindex
| _version_ | 1807865362439471104 |
|---|---|
| adam_text |
CONTENTS
PART
I.
PATHOLOGICAL
BASIS
OF
THERAPY
IN
ALZHEIMER
'
S
DISEASE
CRITERIA
FOR
THE
DIAGNOSIS
OF
ALZHEIMER
'
S
DISEASE
CRITERIA
FOR
THE
CLINICAL
DIAGNOSIS
OF
ALZHEIMER
'
S
DISEASE:
TRANSCULTURAL
ASPECTS
LUIGI
AMADUCCI
AND
MARZIA
BALDERESCHI
.
3
CLINICAL
AND
NEUROPATHOLOGICAL
FINDINGS
FROM
CERAD
JOHN
C.
MORRIS
.
7
DIFFERENTIATING
ALZHEIMER
DISEASE
AND
VASCULAR
DEMENTIA:
REFRAMING
THE
QUESTION
HELENA
CHUI,
QIAN
ZHANG,
JEFFVICTOROFF,
AND
BARBARA
ZAIAS
.
13
NEUROPATHOLOGY
OF
ALZHEIMER
'
S
DISEASE
BASIS
OF
STRUCTURAL
ALZHEIMER
DISEASE
AND
SOME
PATHOGENIC
CONCEPTS
ROBERT
D.
TERRY
.
19
REGIONAL
DISTRIBUTION
OF
NEUROPATHOLOGICAL
CHANGES
IN
ALZHEIMER
'
S
DISEASE
CONSTANTIN
BOURAS,
PANDELIS
GIANNAKOPOULOS,
AND
PHILIPPE
G.
VALLET
.
25
ALZHEIMER
NEUROFIBRILLARY
DEGENERATION:
A
FEASIBLE
AND
KEY
TARGET
FOR
THERAPEUTICS
KHALID
IQBAL,
ALEJANDRA
DEL
C.
ALONSO,
CHENG-XIN
GONG,
NILOUFAR
HAQUE,
SABIHA
KHATOON,
TAKASHI
KUDO,
JIN-JING
PEI,
TOOLSEE
J.
SINGH,
TOSHIHISA
TANAKA,
JIAN-ZHI
WANG,
AND
INGE
GRUNDKE-IQBAL
.
31
DIABETES
AND
DEMENTIA:
A
RETROSPECTIVE
NEUROPATHOLOGIC
STUDY
OF
OLD
DIABETICS
COMPARED
TO
NON-DIABETIC
CONTROLS
JEAN-PIERRE
MICHEL,
PIUS
MULLER,
GABRIEL
GOLD,
WILLIAM
MAC
GEE,
REIHNILD
MULLIGAN,
AND
CONSTANTIN
BOURAS
.
37
VI
CONTENTS
PROCESSING
OF
AMYLOID,
CYTOSKELETAL
DAMAGE
AND
APOLIPOPROTEINS
ISOFORM-SPECIFIC
METABOLISM
OF
APOLIPOPROTEIN
E:
IMPLICATIONS
FOR
ALZHEIMER
'
S
DISEASE
WARREN
J.
STRITTMATTER
.
47
APOLIPOPROTEIN
E4
AND
CHOLINERGIC
ACTIVITY
IN
ALZHEIMER
'
S
DISEASE
'
JUDES
POIRIER,
ISABELLE
AUBERT,
MAIRE-CLAUDE
DELISLE,
REMI
QUIRION,
SERGE
GAUTHIER,
MARTIN
FARLOW,
STEVE
GRACON,
AND
JOSEPHINE
NALBANTOGLU
.
55
A
NEW
FOCUS
ON
CYTOSKELETAL
THERAPY
IN
ALZHEIMER
'
S
DISEASE
HUGO
GEERTS,
RONY
NUYDENS,
MIRJAM
DE
JONG,
AND
GERD
VAN
DE
KIEBOOM
.
61
NOVEL
CATHEPSIN
D
INHIBITORS
PREVENT
THE
/3-SECRETASE-DERIVED
INTRACELLULAR
FORMATION
OF
A
12
KDA
POTENTIALLY
AMYLOIDOGENIC
PRODUCT
IN
HUMAN
CELLS
NATHALIE
CHEVALLIER,
PHILIPPE
MARAMBAUD,
JEAN-PIERRE
VINCENT,
FREDERIC
CHEDER,
JEAN
VIZZAVONA,
PIERRE
FULCRAND,
JEAN
MARTINEZ,
CLAUS-PETERS
BAUR,
MARIA
SPILLANTINI,
AND
MICHEL
GOEDERT
.
67
CELLULAR
AND
TEST
TUBE
MODELS
OF
AMYLOID-/?
FORMATION
HENRYK
M.
WISNIEWSKI,
JANUSZ
FRACKOWIAK,
BOZENA
MAZUR-KOLECKA,
JERZY
WEGIEL,
ABHA
CHAUHAN,
AND
VED
P.S.
CHAUHAN
.
75
EFFECTS
OF
/?
AMYLOID
(1-40)
PEPTIDE
INJECTION
IN
THE
NUCLEUS
BASALIS
GIANCARLO
PEPEU,
LISA
GIOVANNELLI,
FIORELLA
CASAMENTI,
AND
CARLA
SCALI
.
81
/3-AMYLOID
PRECURSOR
PROTEIN
-
ROLE
IN
COGNITIVE
BRAIN
FUNCTION?
GERDAS.
HUBER,
JEAN-LUC
MOREAU,
JAMES
R.
MARTIN,
YANNICK
BAILLY,
JEAN
MARIANI,
AND
BERNARD
BRUGG
.
87
PEPTIDES
INHIBITOR
OF
AMYLOIDOGENESIS
IN
ALZHEIMER
'
S
DISEASE
CLAUDIO
SOTO,
FRANCES
PRELLI,
BLAS
FRANGIONE,
MARK
S.
KINDY,
AND
FREDERICK
DE
BEER
.
91
CELL
DEATH:
EXCITOTOXINS,
APOPTOSIS
AND
HYPOMETABOLISM
APOPTOSIS
AND
ALZHEIMER
'
S
DISEASE:
A
SELF-ASSEMBLY
AND
THE
INITIATION
OF
APOPTOSIS
BY
PLASMA
MEMBRANE
RECEPTOR
CROSS-LINKING
C.
W.
COTMAN,
D.
H.
CRIBBS,
AND
J.
H.
SU
.
99
NMDA
RECEPTOR
DYSFUNCTION
IN
ALZHEIMER
'
S
DISEASE
JOHN
OLNEY,
DAVID
WOZNIAK,
MASAHIKO
ISHIMARU,
AND
NURI
FARBER
.
107
CONTENTS
VII
ROLE
OF
NEURON-GLIA
INTERACTIONS
IN
BRAIN
ENERGY
METABOLISM:
IMPLICATIONS
FOR
NEURODEGENERATIVE
DISORDERS
PIERRE
J.
MAGISTRETTI,
PHILIPPE
BITTAR,
AND
LUC
PELLERIN
.
113
NEUROTROPHINS,
GROWTH
FACTORS
AND
NEUROPROTECTORS
NEUROTROPHINS,
GROWTH
FACTORS
AND
MIMETIC
AGENTS
AS
NEUROPROTECTORS
IN
THE
TREATMENT
OF
ALZHEIMER
'
S
DISEASE
ALVIN
J.
GLASKY,
RONALD
F.
RITZMANN,
MICHEL
P.
RATHBONE,
PAMELA
J.
MIDDLEMISS,
AND
CANDICE
CROCKER
.
119
CORTICAL
SYNAPTOGENESIS
AND
BEHAVIOURAL
CONSEQUENCES
IN
CNS
LESIONED
ANIMALS
RECEIVING
NEUROTROPHIC
FACTOR
THERAPY
A.
CLAUDIO
CUELLO
.
125
ANIMAL
MODELS
APP
KNOCKOUT
AND
APP
OVER-EXPRESSION
IN
TRANSGENIC
MICE
HUI
ZHENG,
GURPARKASH
SINGH,
MINGHAO
JIANG,
MYRNA
TRUMBAUER,
HOWARD
CHEN,
LEX
VAN
DER
PLOEG,
DAVID
SMITH,
DALIP
SIRINATHSINGHJI
,
GERARD
DAWSON,
SUSAN
BOYCE,
CONNIE
VON
KOCH,
AND
SAM
SISODIA
.
133
ALPHA2C-ADRENOCEPTOR
OVEREXPRESSING
MICE
AS
A
MODEL
TO
STUDY
COGNITIVE
FUNCTIONS
OF
ALPHA2-ADRENOCEPTORS
MARKUS
BJORKLUND,
MINNA
RIEKKINEN,
PAAVO
RIEKKINEN
JR.,
JUKKA
SALLINEN,
MIKA
SCHEININ,
JOUNI
SIRVIO,
ANTTI
HAAPALINNA,
RICHARD
E.
LINK,
AND
BRIAN
KOBILKA
.
137
/3-APP-75
1
TRANSGENIC
MICE:
DEFICITS
IN
LEARNING
AND
MEMORY
PAULA
M.
MORAN,
PAUL
C.
MOSER,
LINDA
S.
HIGGINS,
AND
BARBARA
CORDELL
.
145
PART
II.
THE
CHOLINERGIC
SYSTEM
IN
BRAIN
TREATMENT
OF
ALZHEIMER
DISEASE
CENTRAL
AND
PERIPHERAL
CONSEQUENCES
OF
CHOLINERGIC
IMBALANCE
IN
ALZHEIMER
'
S
DISEASE
DANIELA
KAUFER-NACHUM,
ALON
FRIEDMAN,
MEIRA
STERNFELD,
SHLOMO
SEIDMAN,
RACHEL
BEERI,
CHRISTIAN
ANDRES,
AND
HERMONA
SOREQ
.
153
THE
ANATOMY
OF
MONOAMINERGIC-CHOLINERGIC
INTERACTIONS
IN
THE
PRIMATE
BASAL
FOREBRAIN
JOHN
F.
SMILEY
AND
M.
-MARSEL
MESULAM
.
159
VIII
CONTENTS
PHARMACOLOGICAL
INDUCTION
OF
CHOLINERGIC
HYPOFUNCTION
AS
A
TOOL
FOR
EVALUATING
CHOLINERGIC
THERAPIES
ISRAEL
HANIN
.
165
RATIONAL
DESIGN
OF
NEW
ACETYLCHOLINESTERASE
INHIBITORS
MARIO
BRUFANI
AND
LUIGI
FILOCAMO
.
171
ADVANCES
IN
UNDERSTANDING
CHOLINERGIC
BRAIN
NEURONS:
IMPLICATIONS
IN
THE
USE
OF
CITICOLINE
(CDP
CHOLINE)
TO
TREAT
STROKE
RICHARD
J.
WURTMAN,
BOBBY
W
SANDAGE,
JR.,
AND
STEVEN
WARACH
.
179
CHOLINESTERASE
INHIBITORS
IN
ALZHEIMER
DISEASE
TREATMENT
CHOLINESTERASE
INHIBITORS
DO
MORE
THAN
INHIBIT
CHOLINESTERASE
EZIO
GIACOBINI
.
187
LONG-TERM
TACRINE
TREATMENT:
EFFECT
ON
NURSING
HOME
PLACEMENT
AND
MORTALITY
STEPHEN
GRACON,
FRASER
SMITH,
TONI
HOOVER,
DAVID
KNOPMAN,
LON
SCHNEIDER,
KENNETH
DAVIS,
AND
SHEELA
TAIWALKER
.
205
CHOLINESTERASE
INHIBITORS:
AN
OVERVIEW
OF
THEIR
MECHANISMS
OF
ACTION
ALBERT
ENZ
AND
PHILIPP
FLOERSHEIM
.
211
PRECLINICAL
PHARMACOLOGY
OF
METRIFONATE:
A
PROMISE
FOR
ALZHEIMER
THERAPY
BERNARD
H.
SCHMIDT,
VOLKER
C.
HINZ,
ARJAN
BLOKLAND,
FRANZ-JOSEF
VAN
DER
STAAY,
AND
RICHARD
J.
FANELLI
.
217
EPTASTIGMINE:
A
CHOLINERGIC
APPROACH
TO
THE
TREATMENT
OF
ALZHEIMER
'
S
DISEASE
BRUNO
P.
IMBIMBO
.
223
PHENSERINE:
A
SELECTIVE,
LONG-ACTING
AND
BRAIN-DIRECTED
ACETYLCHOLINESTERASE
INHIBITOR
AFFECTING
COGNITION
AND
/3-APP
PROCESSING
NIGEL
H.
GREIG,
DONALD
K.
INGRAM,
WILLIAM
C.
WALLACE,
TADANOBU
UTSUKI,
QIAN-SHENG
YU,
HAROLD
W.
HOLLOWAY,
XUE-FENG
PEI,
VAHRAM
HAROUTUNIAN,
DEBOMOY
K.
LAHIRI,
ARNOLD
BROSSI,
AND
TIMOTHY
T
SONCRANT
.
231
AN
OVERVIEW
OF
THE
DEVELOPMENT
OF
SDZ
ENA
713:
A
BRAIN
SELECTIVE
CHOLINESTERASE
INHIBITOR
RAVI
ANAND,
RICHARD
D.
HARTMAN,
PEGGY
E.
HAYES,
AND
MARGUIRGUIS
GHARABAWI
.
239
PRECLINICAL
AND
CLINICAL
PROGRESS
WITH
HUPERZINE
A:
A
NOVEL
ACETYLCHOLINESTERASE
INHIBITOR
YIFAN
HAN
AND
XICAN
TANG
.
245
CONTENTS
IX
PL
1467:
AN
ORALLY-ACTIVE
ACETYLCHOLINESTERASE
INHIBITOR
AND
2-ADRENOCEPTOR
ANTAGONIST
FOR
ALZHEIMER
'
S
DISEASE
HUGO
M.
VARGAS,
CRAIG
P.
SMITH,
MARY
LI,
GINA
M.
BORES,
ANDREW
GIOVANNI,
LILY
ZHOU,
DANA
CUNNINGHAM,
KAREN
M.
BROOKS,
FERNANDO
CAMACHO,
JAMES
T.
WINSLOW,
DAVID
E.
SELK,
EVA
MARIE
DILEO,
DOUGLAS
J.
TURK,
LARRY
DAVIS,
DAVID
M.
FINK,
DOUGLAS
K.
RUSH,
ANNE
DEKEYNE,
AND
CLAUDE
OBERLANDER
.
251
CHOLINESTERASE
INHIBITORS
AS
THERAPY
IN
ALZHEIMER
'
S
DISEASE:
BENEFIT
TO
RISK
CONSIDERATIONS
IN
CLINICAL
APPLICATION
ROBERT
E.
BECKER,
PAMELA
MORIEARTY,
LATHA
UNNI,
AND
SANDRA
VICARI
.257
PART
III.
NICOTINIC
AND
MUSCARINIC
CHOLINERGIC
AGONISTS
NICOTINIC
AGONISTS
MOLECULAR
HISTOCHEMISTRY
OF
NICOTINIC
RECEPTORS
IN
HUMAN
BRAIN
HANNSJORG
SCHRODER,
ANDREA
WEVERS,
ELKEHAPPICH,
ULRICH
SCHUTZ,
NATASHA
MOSER,
ROBERT
A.L
DE
VOS,
GERARD
VAN
NOORT,
ERNST
N.H.
JANSEN,
EZIO
GIACOBINI,
AND
ALFRED
MAELICKE
.
269
THE
NICOTINIC
CHOLINERGIC
SYSTEM
AND
/3-AMYLOIDOSIS
JENNIFER
A.
COURT,
STEPHEN
LLOYD,
ROBERT
H.
PERRY,
MARTIN
GRIFFITHS,
CHRISTOPHER
MORRIS,
MARY
JOHNSON,
IAN
G.
MCKEITH,
AND
ELAINE
K.
PERRY
.
275
RJR-2403:
A
CNS-SELECTIVE
NICOTINIC
AGONIST
WITH
THERAPEUTIC
POTENTIAL
PATRICK
M.
LIPPIELLO,
MEROUANE
BENCHERIF,
WILLIAM
S.
CALDWELL,
SHERRY
R.
ARRINGTON,
KATHY
W
FOWLER,
M.
ELISA
LOVETTE,
AND
LEIGH
K.
REEVES
.
281
ABT-089:
AN
ORALLY
EFFECTIVE
CHOLINERGIC
CHANNEL
MODULATOR
(CHCM)
WITH
COGNITIVE
ENHANCEMENT
AND
NEUROPROTECTIVE
ACTION
STEPHEN
P.
ARNERIC,
ANTHONY
W.
BANNON,
JORGE
D.
BRIONI,
CLARK
A.
BRIGGS,
MICHAEL
W
DECKER,
MARK
W
HOLLADAY,
KENNAN
C.
MARSH,
DIANA
DONNELLY-ROBERTS,
JAMES
P.
SULLIVAN,
MICHAEL
WILLIAMS,
AND
JERRY
J.
BUCCAFUSCO
.
287
MUSCARINIC
AGONISTS
AND
ANTAGONISTS
BIOCHEMISTRY,
PHARMACODYNAMICS
AND
PHARMACOKINETICS
OF
CI-1002:
A
COMBINED
ANTICHOLINESTERASE
AND
MUSCARINIC
ANTAGONIST
MARK
R.
EMMERLING,
MICHAEL
J.
CALLAHAN,
WILLIAM
J.
LIPINSKI,
M.
DUFF
DAVIS,
LEONARD
COOKE,
HOWARD
BOCKBRADER,
NANCY
JANICZEK,
BILL
MCNALLY,
AND
JUAN
C.
JAEN
.
293
X
CONTENTS
MUSCARINIC
PARTIAL
AGONISTS
IN
THE
SYMPTOMATIC
TREATMENT
OF
ALZHEIMER
'
S
DISEASE
RAJINDER
KUMAR,
EVE
CEDAR,
MICHAEL
S.G.
CLARK,
JULIA
M.
LOUDON,
AND
JAMES
PC.
MCCAFFERTY
.
299
SAFETY
AND
CLINICAL
EFFICACY
OF
SI
2024
IN
PATIENTS
WITH
MILD
TO
MODERATE
ALZHEIMER
'
S
DISEASE
HERVE
ALLAIN,
DAVID
GUEZ,
ERIC
NEUMAN,
MURIEL
MALBEZIN,
JEAN
LEPAGNOL,
AND
FLORENCE
MAHIEUX
.
305
PHARMACOLOGICAL
CHARACTERIZATION
OF
PD151832:
AN
ML
MUSCARINIC
RECEPTOR
AGONIST
ROY
D.
SCHWARZ,
MICHAEL
J.
CALLAHAN,
ROBERT
E.
DAVIS,
MARK
R.
EMMERLING,
JUAN
C.
JAEN,
WILLIAM
LIPINSKI,
THOMAS
A.
PUGSLEY,
CHARLOTTE
RABY,
CAROLYN
J.
SPENCER,
KATHARYN
SPIEGEL,
HAILE
TECLE,
AND
MARK
R.
BRANN
.
311
THE
POTENTIAL
OF
ANTIOXIDANT
THERAPY
NOVEL
ML
AGONISTS:
FROM
SYMPTOMATIC
TREATMENT
TOWARDS
DELAYING
THE
PROGRESSION
OF
ALZHEIMER
'
S
DISEASE
ABRAHAM
FISHER,
RACHEL
HARING,
ZIPPORA
PITTEL,
DAVID
GURWITZ,
YISHAI
KARTON,
HAIM
MESHULAM,
DANIELE
MARCIANO,
RACHEL
BRANDEIS,
ELIAHU
HELDMAN,
EINAT
SADOT,
JACOB
BARG,
LEAH
BEHAR,
AND
IRIT
GINZBURG
.
317
FREE
RADICAL
SCAVENGERS
BLOCK
THE
ACTIONS
OF
(3
AMYLOID
ON
NEURONS
IN
TISSUE
CULTURE
J.
STEVEN
RICHARDSON
AND
YAN
ZHOU
.323
THERAPEUTIC
STRATEGIES
IN
ALZHEIMER
'
S
DISEASE
M.
FLINT
BEAL
.
329
NEW
SYNTHETIC
BIOANTIOXIDANTS:
ACETYLCHOLINESTERASE
(ACHE)
FAINA
I.
BRAGINSKAYA,
ELENA
M.
MOLOCHKINA,
OLGA
M.
ZORINA,
IRINA
B.
OZEROVA,
AND
ELENA
B.
BURLAKOVA
.337
RATIONALE
TO
TREAT
ALZHEIMER
'
S
DISEASE
WITH
SELEGILINE
-
CAN
WE
PREVENT
THE
PROGRESSION
OF
THE
DISEASE?
PAAVO
J.
RIEKKINEN
SR.,
KEIJO
J.
KOIVISTO,
EEVA-LIISA
HELKALA,
KARI
J.REINIKAINEN,
OLAVI
KILKKU,
AND
ESA
HEINONEN
.
343
THE
POTENTIAL
FOR
ANTI-INFLANUNATORY
THERAPY
INFLAMMATORY
PROCESSES:
ANTI-INFLAMMATORY
THERAPY
PAUL
S.
AISEN,
DEBORAH
B.
MARIN,
AND
KENNETH
L.
DAVIS
.
349
CONTENTS
XI
PROPENTOFYLLINE:
PRECLINICAL
DATA
KARL
A.
RUDOLPHI
.
355
PROPENTOFYLLINE
(HWA
285):
A
SUBGROUP
ANALYSIS
OF
PHASE
III
CLINICAL
STUDIES
IN
ALZHEIMER
'
S
DISEASE
AND
VASCULAR
DEMENTIA
BARBARA
KITTNER
FOR
THE
EUROPEAN
PROPENTOFYLLINE
STUDY
GROUP
.
361
ANAPSOS:
NEW
THERAPEUTIC
STRATEGIES
FOR
NEURODEGENERATION
AND
BRAIN
AGING
WITH
NEUROIMMUNOTROPHIC
FACTORS
X.
ANTON
ALVAREZ,
RAQUEL
ZAS,
RAQUEL
LAGARES,
LUCIA
FERNANDEZ-NOVOA,
ANDRES
FRANCO-MASIDE,
JOSE
J.
MIGUEL-HIDALGO,
RAMON
CACABELOS,
JOAQUIN
DIAZ,
AND
JOSE
M.
SEMPERE
.
367
PART
TV.
DEVELOPMENT
OF
NEW
THERAPIES
IN
ALZHEIMER
DISEASE
DESIGN
OF
CLINICAL
TRIALS
CLINICAL
TRIALS
TO
PREVENT
ALZHEIMER
'
S
DISEASE
IN
A
POPULATION
AT-RISK
MICHAEL
GRUNDMAN
AND
LEON
J.
THAL
.
375
EFFECTS
ON
DECLINE
OR
DETERIORATION
SERGE
GAUTHIER,
JUDES
POIRIER,
AND
JULIAN
GRAY
.
381
THE
BRIDGING
STUDY:
OPTIMIZING
THE
DOSE
FOR
PHASELL/III
NEAL
R.
CUTLER
AND
JOHN
J.
SRAMEK
.
387
ASSESSMENT
OF
THERAPEUTIC
STRATEGIES
FOR
SLOWING
PROGRESSION
OF
ALZHEIMER
'
S
DISEASE
MICHAEL
J.
PONTECORVO
AND
WIM
PARYS
.393
POTENTIAL
FOR
PROGRESS
IN
THE
THERAPEUTICS
OF
ALZHEIMER
'
S
DISEASE:
UNANSWERED
QUESTIONS
KENNETH
L.
DAVIS
.
399
ADVANCES
IN
ASSESSMENT
THE
ALZHEIMER
'
S
DISEASE
ASSESSMENT
SCALE:
MODIFICATIONS
THAT
CAN
ENHANCE
ITS
USE
IN
FUTURE
CLINICAL
TRIALS
RICHARD
C.
MOHS,
DEBORAH
MARIN,
CYNTHIA
R.
GREEN,
AND
KENNETH
L.
DAVIS
.
407
AN
ITEM
POOL
TO
ASSESS
ACTIVITIES
OF
DAILY
LIVING
IN
ALZHEIMER
'
S
DISEASE
DOUGLAS
R.
GALASKO
AND
DAVID
BENNETT
FOR
THE
ALZHEIMER
'
S
DISEASE
COOPERATIVE
STUDY
.
413
XII
CONTENTS
SEVERE
IMPAIRMENT
BATTERY:
A
POTENTIAL
MEASURE
FOR
ALZHEIMER
'
S
DISEASE
CLINICAL
TRIALS
FREDERICK
A.
SCHMITT,
J.
WESSON
ASHFORD,
STEVEN
FERRIS,
JOAN
MACKELL,
JUDITH
SAXTON,
LON
SCHNEIDER,
CHRISTOPHER
CLARK,
CHRIS
ERNESTO,
KIMBERLY
SCHAFER,
AND
LEON
THAL
FOR
THE
ALZHEIMER
'
S
DISEASE
COOPERATIVE
STUDY
UNITS
AND
THE
ADCS
INSTRUMENT
AND
SEVERE
IMPAIRMENT
COMMITTEES
.
419
VALIDITY
AND
RELIABILITY
OF
THE
ALZHEIMER
'
S
DISEASE
COOPERATIVE
STUDY-CLINICAL
GLOBAL
IMPRESSION
OF
CHANGE
(ADCS-CGIC)
LON
S.
SCHNEIDER,
JASON
T.
OLIN,
RACHELLE
S.
DOODY,
CHRISTOPHER
M.
CLARK,
JOHN
C.
MORRIS,
BARRY
REISBERG,
STEVEN
H.
FERRIS,
FREDERICK
A.
SCHMITT,
MICHAEL
GRUNDMAN,
AND
RONALD
G.
THOMAS
.
425
ADVANTAGES
OF
THE
"
TIME-INDEX
"
METHOD
FOR
MEASUREMENT
OF
ALZHEIMER
DEMENTIA:
ASSESSMENT
OF
METRIFONATE
BENEFIT
J.
WESSON
ASHFORD,
FREDERICK
A.
SCHMITT,
DANIEL
WERMELING,
FLORIAN
BIEBER,
JOHN
ORAZEM,
AND
BARBARA
GULANSKI
.
431
SPECT
AND
PET
PET-STUDIES
USING
11C-TZTP
DERIVATIVES
FOR
THE
VISUALIZATION
OF
MUSCARINIC
RECEPTORS
IN
THE
HUMAN
BRAIN
HENRIKNYBACK,
CHRISTER
HALLDIN,
PER
KARLSSON,
YOSHIFUMI
NAKASHIMA,
LARSFARDE,
PER
SAUERBERG,
HARLAN
E.
SHANNON,
AND
FRANK
P.
BYMASTER
.
435
PET
IMAGING
OF
NICOTINIC
RECEPTORS
IN
ALZHEIMER
'
S
DISEASE:
IMPLICATION
WITH
DIAGNOSIS
AND
DRUG
TREATMENT
AGNETA
NORDBERG
.
439
CEREBRAL
SPECT
IMAGING:
ADVANCES
IN
RADIO-PHARMACEUTICALS
AND
QUANTITATIVE
ANALYSIS
DANIEL
O.
SLOSMAN
AND
PIERRE
J.
MAGISTRETTI
.
445
IN
VIVO
IMAGING
OF
ANTICHOLINESTERASE
DRUGS
USED
IN
ALZHEIMER
'
S
DISEASE
B.
TAVITIAN,
S.
PAPPATA,
F.
BRANLY,
A.
JOBERT,
A.
DALGER,
E.
DUMONT,
F.
SIMONNET,
J.
GRASSI,
C.
CROUZEL,
ANDL.
DIGIAMBERARDINO
.
451
SPECT
SCAN
AND
EFFICACY
OF
THERAPY
IN
ALZHEIMER
'
S
DISEASE
JACQUES
DARCOURT,
OCTAVE
MIGNECO,
PHILIPPE
ROBERT,
AND
MICHEL
BENOIT
.
457
POTENTIAL
MARKERS
OF
DISEASE
PROGRESSION
AND
DRUG
EFFICACY
IN
ALZHEIMER
'
S
DISEASE
MRI
AND
COGNITIVE
MARKERS
OF
PROGRESSION
AND
RISK
OF
ALZHEIMER
DISEASE
STEVEN
H.
FERRIS
AND
MONY
J.
DE
LEON
.
463
CONTENTS
XIII
BRAIN
MAPPING
AND
TRANSCRANIAL
DOPPLER
ULTRASONOGRAPHY
IN
ALZHEIMER
DISEASE
DRUG
MONITORING
RAMON
CACABELOS,
JOSE
CAAMANO,
DOLORES
VINAGRE,
JOSE
I.
LAO,
KATRIN
BEYER,
AND
ANTON
ALVAREZ
.
469
APOE
GENOTYPE
AND
MRI
VOLUMETRY:
IMPLICATION
FOR
THERAPY
HILKKA
S.
SOININEN,
MAARIT
LEHTOVIRTA,
MIKKO
P.
LAAKSO,
KAARINA
PARTANEN,
PAAVO
RIEKKINEN
JR,
MERJA
HALLIKAINEN,
TUOMO
HANNINEN,
KEIJO
KOIVISTO,
AND
PAAVO
J.
RIEKKINEN
SR.
.
475
TREATMENT
OF
BEHAVIORAL
AND
PSYCHOSOCIAL
DISTURBANCES
GROUP
PSYCHOTHERAPY
JOSE
GUIMON
AND
ELISABETH
BASAGUREN
.
481
NON
COGNITIVE
SYMPTOMS
IN
ALZHEIMER
'
S
DISEASE
PHILIPPE
H.
ROBERT,
CHARLES
HENRI
BEAU,
VALERIE
MIGNECO,
VALERIE
AUBIN-BRUNET,
AND
GUY
DARCOURT
.
487
DEPRESSION
AND
ALZHEIMER
'
S
DISEASE
CARL-GERHARD
GOTTFRIES
.
495
PSYCHOMOTOR
THERAPY
AND
ALZHEIMER
'
S
DISEASE
JACQUES
RICHARD,
PHILIPPE
BOVIER,
AND
JEAN-PHILIPPE
BOCKSBERGER
.
501
BEHAVIORAL
TECHNIQUES
FOR
TREATMENT
OF
PATIENTS
WITH
ALZHEIMER
'
S
DISEASE
LINDA
TERI
.
507
TREATMENT
OF
PSYCHOSOCIAL
DISTURBANCES
JEAN-MARIE
LEGER,
JEAN-PIERRE
CLEMENT,
AND
SANDRINE
PAULIN
.
513
SEROTONINERGIC
SYMPTOMATOLOGY
IN
DEMENTIA
VALERIE
M.
AUBIN-BRUNET,
CHARLES
H.
BEAU,
GENEVIEVE
ASSO,
PHILIPPE
H.
ROBERT,
AND
GUY
DARCOURT
.
521
PART
V.
SOCIAL
ISSUE
IN
ALZHEIMER
DISEASE
LEGAL
AND
ETHICAL
ISSUES
INFORMED
CONSENT
AND
ALZHEIMER
DISEASE
RESEARCH:
INSTITUTIONAL
REVIEW
BOARD
POLICIES
AND
PRACTICES
THEODORE
R.
LEBLANG
AND
JEAN
L.
KIRCHNER
.
529
LEGAL
ISSUES
IN
ALZHEIMER
DISEASE
RESEARCH
IN
FRANCE
ALAIN
GARAY
.
535
XIV
CONTENTS
ETHICAL
PROBLEMS
IN
THERAPEUTIC
RESEARCH
IN
ALZHEIMER
'
S
DISEASE
PATIENTS
STEPHANIE
THIBAULT,
LUCETTE
LACOMBLEZ
AND
CHRISTIAN
DEROUESNE
.
541
MAKING
CONSENT
WORK
IN
ALZHEIMER
DISEASE
RESEARCH
GEORGE
J.
AGICH
.
549
SOCIO-ECONOMIC
AS
PECTS
OF
ALZHEIMER
DISEASE
TREATMENT
INDUSTRY
PERSPECTIVES
ON
THE
MARKETING
OF
ANTI-ALZHEIMER
DISEASE
THERAPY
ROBERT
VAN
DER
MARK
.
555
CODEM:
A
LONGITUDINAL
STUDY
ON
ALZHEIMER
DISEASE
COSTS
MARCO
TRABUCCHI,
KARIN
M.
GHISLA,
AND
ANGELO
BIANCHETTI
.
561
HEALTH
ECONOMIC
ASPECTS
OF
ALZHEIMER
'
S
DISEASE
AND
THE
IMPLICATIONS
FOR
DRUG
DEVELOPMENT
AND
PRICING
M.
HARDENS
.
567
INTERNATIONAL
HARMONIZATION
OF
DRUG
GUIDELINES
INTERNATIONAL
WORKING
GROUP
FOR
THE
HARMONIZATION
OF
DEMENTIA
DRUG
GUIDELINES:
A
PROGRESS
REPORT
PETER
J.
WHITEHOUSE
.
573
DEVELOPING
SAFE
AND
EFFECTIVE
ANTIDEMENTIA
DRUGS
PAUL
D.
LEBER
.
579
A
JAPANESE
PERSPECTIVE
ON
THE
WORK
OF
THE
INTERNATIONAL
GROUP
ON
HARMONIZATION
OF
DRUG
GUIDELINES
AKIRA
HOMMA
.
585
RESEARCH
PRIORITIES
IN
ALZHEIMER
DISEASE
TREATMENT
-
AN
INTERNATIONAL
PERSPECTIVE
THE
RONALD
AND
NANCY
REAGAN
RESEARCH
INSTITUTE
OF
THE
ALZHEIMER
'
S
ASSOCIATION
Z.
S.
KHACHATURIAN
AND
T
S.
RADEBAUGH
.
591
SUBJECT
INDEX
.
599
AUTHOR
INDEX
.
609 |
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV013377434 |
| classification_rvk | YG 4000 |
| ctrlnum | (OCoLC)469734132 (DE-599)BVBBV013377434 |
| dewey-full | 618.976831 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 618 - Gynecology, obstetrics, pediatrics, geriatrics |
| dewey-raw | 618.976 831 |
| dewey-search | 618.976 831 |
| dewey-sort | 3618.976 3831 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 c 4500</leader><controlfield tag="001">BV013377434</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">001009s1997 d||| |||| 00||| eng d</controlfield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">949348589</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3764338792</subfield><subfield code="9">3-7643-3879-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0817638792</subfield><subfield code="9">0-8176-3879-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)469734132</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV013377434</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-634</subfield></datafield><datafield tag="082" ind1="1" ind2=" "><subfield code="a">618.976 831</subfield><subfield code="2">22</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YG 4000</subfield><subfield code="0">(DE-625)153494:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Alzheimer disease</subfield><subfield code="b">from molecular biology to therapy</subfield><subfield code="c">Robert E. Becker ... ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boston [u.a.]</subfield><subfield code="b">Birkhäuser</subfield><subfield code="c">1997</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XIV, 613 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Advances in Alzheimer disease therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Alzheimer, Maladie d' - Aspect moléculaire</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Alzheimer, Maladie d' - Thérapeutique</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Alzheimerkrankheit</subfield><subfield code="0">(DE-588)4112510-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Alzheimerkrankheit</subfield><subfield code="0">(DE-588)4112510-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Becker, Robert E.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009124399&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-009124399</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV013377434 |
| illustrated | Illustrated |
| indexdate | 2024-08-20T00:46:03Z |
| institution | BVB |
| isbn | 3764338792 0817638792 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-009124399 |
| oclc_num | 469734132 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-634 |
| owner_facet | DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-634 |
| physical | XIV, 613 S. graph. Darst. |
| publishDate | 1997 |
| publishDateSearch | 1997 |
| publishDateSort | 1997 |
| publisher | Birkhäuser |
| record_format | marc |
| series2 | Advances in Alzheimer disease therapy |
| spelling | Alzheimer disease from molecular biology to therapy Robert E. Becker ... ed. Boston [u.a.] Birkhäuser 1997 XIV, 613 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Advances in Alzheimer disease therapy Alzheimer, Maladie d' - Aspect moléculaire ram Alzheimer, Maladie d' - Thérapeutique ram Therapie (DE-588)4059798-2 gnd rswk-swf Alzheimerkrankheit (DE-588)4112510-1 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Alzheimerkrankheit (DE-588)4112510-1 s Therapie (DE-588)4059798-2 s DE-604 Becker, Robert E. Sonstige oth DNB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009124399&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Alzheimer disease from molecular biology to therapy Alzheimer, Maladie d' - Aspect moléculaire ram Alzheimer, Maladie d' - Thérapeutique ram Therapie (DE-588)4059798-2 gnd Alzheimerkrankheit (DE-588)4112510-1 gnd |
| subject_GND | (DE-588)4059798-2 (DE-588)4112510-1 (DE-588)4143413-4 |
| title | Alzheimer disease from molecular biology to therapy |
| title_auth | Alzheimer disease from molecular biology to therapy |
| title_exact_search | Alzheimer disease from molecular biology to therapy |
| title_full | Alzheimer disease from molecular biology to therapy Robert E. Becker ... ed. |
| title_fullStr | Alzheimer disease from molecular biology to therapy Robert E. Becker ... ed. |
| title_full_unstemmed | Alzheimer disease from molecular biology to therapy Robert E. Becker ... ed. |
| title_short | Alzheimer disease |
| title_sort | alzheimer disease from molecular biology to therapy |
| title_sub | from molecular biology to therapy |
| topic | Alzheimer, Maladie d' - Aspect moléculaire ram Alzheimer, Maladie d' - Thérapeutique ram Therapie (DE-588)4059798-2 gnd Alzheimerkrankheit (DE-588)4112510-1 gnd |
| topic_facet | Alzheimer, Maladie d' - Aspect moléculaire Alzheimer, Maladie d' - Thérapeutique Therapie Alzheimerkrankheit Aufsatzsammlung |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009124399&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT beckerroberte alzheimerdiseasefrommolecularbiologytotherapy |